Otros idiomas DarioHealth Corp.

Acciones

DRIO

US23725P2092

Mercado cerrado - Nasdaq Otros sitios de cotización 22:00:00 26/04/2024			Varia. Cinco días.	Varia. 1 de enero.
1,48 ^USD	+0,68 %		+27,59 %	-13,95 %

25/04	DarioHealth Corp. Publica un nuevo estudio revisado por expertos que profundiza en el conjunto de pruebas de que la gestión de las afecciones cardiometabólicas en una plataforma integrada mejora los resultados clínicos	CI
18/04	DarioHealth Corp. firma con dos empleadores para la suite cardiometabólica con solución Glp-1 integrada	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Dario Publishes New Peer-Reviewed Study that Deepens the Body of Evidence that Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes	25/04
DarioHealth Corp. Publishes New Peer-Reviewed Study That Deepens the Body of Evidence That Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes	25/04
Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution	18/04
DarioHealth Corp. Signs Two Employers for Cardiometabolic Suite with Integrated Glp-1 Solution	18/04
Dario Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health	10/04
DarioHealth Corp. Publishes Two New Peer-Reviewed Studies Demonstrating Impact of Digital Behavioral Health	10/04
TWO NATIONAL EMPLOYERS SELECT DARIO S INTEGRATED CHRONIC CONDITION SOLUTION TO IMPROVE EMPLOYEE HEALTH	03/04
Two National Employers Select Dario's Integrated Chronic Condition Solution to Improve Employee Health	02/04
Two National Employers Select DarioHealth Corp.'S Integrated Chronic Condition Solution to Improve Employee Health	02/04
DarioHealth : Q4 and full year 2023 earnings call transcript	01/04
DarioHealth Reports Fourth Quarter and Full-Year 2023 Financial and Operating Results	28/03
DarioHealth Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	28/03
North American Morning Briefing : Stocks Set for -2-	28/03
DARIOHEALTH TO REPORT FOURTH QUARTER 2023 RESULTS ON THURSDAY, MARCH 28TH	21/03
North American Morning Briefing : Investors -2-	21/03
New Research from Dario Demonstrates Ability to Deliver Improved Health Outcomes with Integrated Solution for Members Managing Weight and Blood Glucose with or without GLP-1 Medications	12/03
DarioHealth Corp. Announces Two New Clinical Studies Presented at the 17th International Conference on Advanced Technologies and Treatments for Diabetes 2024	12/03
DARIOHEALTH TO PARTICIPATE IN THE COWEN 43RD ANNUAL HEALTHCARE CONFERENCE	28/02
DarioHealth Corp. Appoints Tomer Ben-Kiki as Chief Operating Officer	21/02
Dario acquires Twill creating one of the most comprehensive digital health platform across the most prevalent chronic conditions	21/02

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas DarioHealth Corp.

Acciones

DRIO

US23725P2092

Otros idiomas

Filtros